Radius Health (RDUS): Price to Sales

Corporate company logo of Radius Health (RDUS)

Against the backdrop of the global transition to a circular metal economy, the current P/S dynamics on GURU.Markets establish the 0.30 level, which reflects the state of the market valuation parameter. Radius Recycling, Inc. (RDUS) brand expertise in treating bone pathologies earns physician trust, while stable demand for the drug Tymlos ensures high cash flow margins, confirming the fundamental resilience of the business.

Radius Recycling - RDUS P/S Multiple (period 07/04/2022 - 07/26/2025)

Metric breakdowns and analytics for Radius Health (RDUS)

- current price and projected stock value:
Price Chart radiuspharm.com|RDUS - Price Target Chart
- stock exchange capitalization data:
Market Value Radius Health|RDUS - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Radius Recycling|RDUS - Book Capitalization|Market Capitalization to Book Value radiuspharm.com|RDUS - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Radius Recycling, Inc.|RDUS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Radius Pharmaceuticals|RDUS - Company Debts|Debt to Net Assets Ratio Radius Health|RDUS - Company Long-Term Debts|Company Short-Term Debts Radius Recycling|Immediate Liquidity Ratio radiuspharm.com
- financial results and valuation multiples details:
RDUS - Net Profit|Company Profit Forecast Radius Recycling, Inc.|RDUS - Price to Earnings Ratio|Forward P/E Multiple Radius Recycling Inc.|RDUS - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Radius Health|RDUS - Operating profit before deduction of amortization|Earnings per share for the trailing year Radius Recycling|RDUS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months radiuspharm.com|RDUS - Earnings growth in current year|Expected net earnings per share growth next year Radius Recycling, Inc.
- issuer revenue and sales details:
RDUS - Revenue and Sales Volume|Company Future Sales Volume radiuspharm.com|RDUS - Market Cap to Revenue|Market Cap to Future Revenue Ratio Radius Health
Fundamental company analysis:radiuspharm.com, RDUS
Core merchandise of Radius Recycling, Inc.

Radius Recycling, Inc. (RDUS) occupies a stable niche in the scrap metal recycling cycle, where the efficiency of converting decommissioned equipment into raw materials directly determines market value. Analyzing P/S fluctuations allows for an assessment of how many dollars of market capitalization the market assigns to each dollar of revenue, revealing whether the asset is overbought or carries a hidden discount relative to US industry standards for long-term planning.

Competing companies

Price-to-Revenue Ratio ASND (ascendispharma.com)|Price-to-Revenue Ratio Madrigal Pharmaceuticals, Inc. MDGL|Corcept Therapeutics Inc. (CORT) - Price to Sales|RYTM - Price-to-Revenue Ratio|AKRO: Price-to-Revenue Ratio|MTSR: P/S Multiple|MLTX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Crinetics|NewAmsterdam Pharma Company (NAMS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Soleno (SLNO)|Market Cap to Revenue Amicus Corp FOLD|Price-to-Revenue Ratio 89bio, Inc. ETNB|Market Capitalization-to-Revenue Ratio AGIO|Structure Therapeutics Inc. - P/S Multiple|MDXG - P/S Multiple|RZLT: P/S Multiple|Market Cap to Revenue Ratio LXRX|MBX (MBX Biosciences Inc) - P/S Multiple|altimmune.com (ALT) - Price-to-Revenue Coefficient|Market Cap to Revenue AARD (Aardvark Therapeutics)|P/S Multiple Sagimet Biosciences, Inc. (SGMT)|Price-to-Revenue Ratio BioAge Labs Inc. BIOA|Price-to-Revenue Coefficient Biomea Fusion Corp (BMEA)|QNCX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio GUTS (fractyl.com)|vtvtherapeutics.com (VTVT) - Price-to-Revenue Ratio|Agape ATP - Market Capitalization-to-Revenue Ratio|PLUR (Pluristem Therapeutics) - P/S Multiple|Price to Sales Synlogic Corp SYBX|P/S Multiple LPCN|Market Cap to Revenue matinasbiopharma.com MTNB|Spruce Biosciences, Inc. - Market Cap to Revenue|Galecto Inc (GLTO) - Price to Sales|Carmell Corp - P/S Multiple|Lumos Therapeutics (LUMO) - Market Cap to Revenue|Organovo Holdings, Inc. (ONVO) - Price-to-Revenue Ratio